These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 8524426)

  • 21. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor G-CSF].
    Heinz P; Müller H; Bauer M
    Psychiatr Prax; 1994 Mar; 21(2):81. PubMed ID: 7515190
    [No Abstract]   [Full Text] [Related]  

  • 23. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
    Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
    Comacchio C; Dusi N; Lasalvia A
    J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
    [No Abstract]   [Full Text] [Related]  

  • 25. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Cytokines and agranulocytosis induced by clozapine.
    Malek-Ahmadi P
    Can J Psychiatry; 1996 Nov; 41(9):603. PubMed ID: 8946085
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of clozapine-induced agranulocytosis using granulocyte colony-stimulating factor].
    Gruner U; tho Pesch S; Spittler S; Schaefer HE; Peters U
    Dtsch Med Wochenschr; 1994 Oct; 119(43):1467-70. PubMed ID: 7525175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic dilemmas in treatment-resistant bipolar patients.
    Bota RG; Sagduyu K
    South Med J; 2008 Jun; 101(6):584. PubMed ID: 18475231
    [No Abstract]   [Full Text] [Related]  

  • 31. Granulocyte-colony stimulating factor therapy in drug-induced agranulocytosis.
    Mani S; Barry M; Concato J
    Arch Intern Med; 1993 Nov; 153(21):2500-1. PubMed ID: 7692832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y; Scholte WF
    Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis.
    Nielsen H
    J Intern Med; 1993 Nov; 234(5):529-31. PubMed ID: 7693847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
    Góra-Tybor J; Krykowski E; Robak T
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].
    van Gool AR; van der Velden MT; Oosten AW; van Meerten E; Verhoeven WM; Loonen AJ
    Tijdschr Psychiatr; 2008; 50(10):673-8. PubMed ID: 18951346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA; Lindenmayer JP
    J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis.
    Ibáñez L; Sabaté M; Ballarín E; Puig R; Vidal X; Laporte JR;
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):224-8. PubMed ID: 18181220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
    Lally J; Malik S; Whiskey E; Taylor DM; Gaughran FP; Krivoy A; Flanagan RJ; Mijovic A; MacCabe JH
    J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clozapine-induced agranulocytosis].
    Valevski A; Modai I; Weizman A
    Harefuah; 1994 Jan; 126(1):32-5. PubMed ID: 7511125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.